These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 23347877)

  • 1. 5-Iodo-2-aminoindan (5-IAI): chemistry, pharmacology, and toxicology of a research chemical producing MDMA-like effects.
    Coppola M; Mondola R
    Toxicol Lett; 2013 Mar; 218(1):24-9. PubMed ID: 23347877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aminoindanes--the next wave of 'legal highs'?
    Sainsbury PD; Kicman AT; Archer RP; King LA; Braithwaite RA
    Drug Test Anal; 2011; 3(7-8):479-82. PubMed ID: 21748859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MDAI (5,6-methylenedioxy-2-aminoindane; 6,7-dihydro-5H-cyclopenta[f][1,3]benzodioxol-6-amine; 'sparkle'; 'mindy') toxicity: a brief overview and update.
    Corkery JM; Elliott S; Schifano F; Corazza O; Ghodse AH
    Hum Psychopharmacol; 2013 Jul; 28(4):345-55. PubMed ID: 23881883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Neuropsychopharmacology and Toxicology of 3,4-methylenedioxy-N-ethyl-amphetamine (MDEA).
    Freudenmann RW; Spitzer M
    CNS Drug Rev; 2004; 10(2):89-116. PubMed ID: 15179441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthetic cathinones: chemistry, pharmacology and toxicology of a new class of designer drugs of abuse marketed as "bath salts" or "plant food".
    Coppola M; Mondola R
    Toxicol Lett; 2012 Jun; 211(2):144-9. PubMed ID: 22459606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toxicity of MDA (3,4-methylenedioxyamphetamine) considered for relevance to hazards of MDMA (Ecstasy) abuse.
    Davis WM; Hatoum HT; Waters IW
    Alcohol Drug Res; 1987; 7(3):123-34. PubMed ID: 2881551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 5-Iodo-2-aminoindan, a nonneurotoxic analogue of p-iodoamphetamine.
    Nichols DE; Johnson MP; Oberlender R
    Pharmacol Biochem Behav; 1991 Jan; 38(1):135-9. PubMed ID: 1826785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. (+)-N-methyl-1-(1,3-benzodioxol-5-yl)-2-butanamine as a discriminative stimulus in studies of 3,4-methylenedioxy-methamphetamine-like behavioral activity.
    Oberlender R; Nichols DE
    J Pharmacol Exp Ther; 1990 Dec; 255(3):1098-106. PubMed ID: 1979813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estimation of community-wide drugs use via stereoselective profiling of sewage.
    Kasprzyk-Hordern B; Baker DR
    Sci Total Environ; 2012 Apr; 423():142-50. PubMed ID: 22404981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of MDA (the "love drug") and methamphetamine in Toronto by unsuspecting users of ecstasy (MDMA).
    Kalasinsky KS; Hugel J; Kish SJ
    J Forensic Sci; 2004 Sep; 49(5):1106-12. PubMed ID: 15461119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Do we need high-resolution MS in forensic and clinical toxicology?
    Meyer MR
    Bioanalysis; 2013 May; 5(10):1161-3. PubMed ID: 23721440
    [No Abstract]   [Full Text] [Related]  

  • 12. 4-methylamphetamine (4-MA): chemistry, pharmacology and toxicology of a new potential recreational drug.
    Coppola M; Mondola R
    Mini Rev Med Chem; 2013 Dec; 13(14):2097-101. PubMed ID: 24195663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ecstasy: towards an understanding of the biochemical basis of the actions of MDMA.
    Rattray M
    Essays Biochem; 1991; 26():77-87. PubMed ID: 1685707
    [No Abstract]   [Full Text] [Related]  

  • 14. Research chemicals marketed as legal highs: the case of pipradrol derivatives.
    Coppola M; Mondola R
    Toxicol Lett; 2012 Jul; 212(1):57-60. PubMed ID: 22564760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Keeping pace with NPS releases: fast GC-MS screening of legal high products.
    Elie MP; Elie LE; Baron MG
    Drug Test Anal; 2013 May; 5(5):281-90. PubMed ID: 23297247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 3,4-Methylenedioxymethamphetamine (MDMA) and other amphetamine derivatives.
    Bost RO
    J Forensic Sci; 1988 Mar; 33(2):576-87. PubMed ID: 2897421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Contaminants in illegal amphetamine. Basic contaminants in drug market 3,4-(methylenedioxy)methylamphetamine].
    Verweij AM
    Arch Kriminol; 1991; 188(5-6):154-8. PubMed ID: 1686826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 4,4'-DMAR: chemistry, pharmacology and toxicology of a new synthetic stimulant of abuse.
    Coppola M; Mondola R
    Basic Clin Pharmacol Toxicol; 2015 Jul; 117(1):26-30. PubMed ID: 25819702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analytical toxicology of emerging drugs of abuse.
    Peters FT; Martinez-Ramirez JA
    Ther Drug Monit; 2010 Oct; 32(5):532-9. PubMed ID: 20814349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determination of a new designer drug, N-hydroxy-3,4-methylenedioxymethamphetamine and its metabolites in rats using ultra-performance liquid chromatography-tandem mass spectrometry.
    Kikura-Hanajiri R; Kawamura M; Miyajima A; Sunouchi M; Goda Y
    Forensic Sci Int; 2010 May; 198(1-3):62-9. PubMed ID: 20299167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.